← Open Payments lookup

JEREMY SCHMIDT: Open Payments

NPI 1184892622 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$23,444 in 188 payments from 30 companies in 2025. Trend: 2023 $33,577 · 2024 $21,383 · 2025 $23,444

Speaker / faculty: $16,319Food & beverage: $4,035Travel & lodging: $3,090
CompanyPaymentsAmount
Novo Nordisk Inc32$12,013
Lilly USA, LLC28$8,632
Bayer Healthcare Pharmaceuticals Inc.20$351
Corcept Therapeutics10$296
Amgen Inc.11$233
Madrigal Pharmaceuticals4$185
Dexcom, Inc.5$172
RECORDATI_RARE_DISEASES_INC.10$166
Esperion Therapeutics, Inc.9$150
Amneal Pharmaceuticals LLC9$145

Products named: Ozempic, MOUNJARO, Kerendia, JARDIANCE, Korlym, Wegovy, REZDIFFRA, Dexcom G6 Transmitter.

Industry payments across TX — which companies pay providers there.